# DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease

Study · id `cardio:ct-nct07795398` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07795398](<https://clinicaltrials.gov/study/NCT07795398>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07795398

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 7000 participants.

## Technical summary

Registry record NCT07795398. Randomized; no masking; primary purpose treatment. Start 2026-09-30 (actual); primary completion 2029-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 7000 participants (planned count; ClinicalTrials.gov record NCT07795398, source copy `cardio:ctgov-nct07795398-2026-10-05`, retrieved 2026-10-26)
- Started: 2026-09-30 (actual) (ClinicalTrials.gov record NCT07795398, source copy `cardio:ctgov-nct07795398-2026-10-05`, retrieved 2026-10-26)
- Primary completion: 2029-10 (anticipated) (ClinicalTrials.gov record NCT07795398, source copy `cardio:ctgov-nct07795398-2026-10-05`, retrieved 2026-10-26)
- Completion: 2029-10 (anticipated) (ClinicalTrials.gov record NCT07795398, source copy `cardio:ctgov-nct07795398-2026-10-05`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT07795398, source copy `cardio:ctgov-nct07795398-2026-10-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07795398-2026-10-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease
- Acronym: DAN-RELEASE
- Condition: Ischemic Heart Disease
- Condition: Ischemic Heart Disease Chronic
- Condition: Chronic Coronary Syndrome
- Condition: Myocardial Infarction
- Condition: Percutaneous Coronary Intervention
- Condition: Coronary Artery Bypass Graft
- Condition: Aspirin
- Condition: Aspirin Causing Adverse Effects in Therapeutic Use
- Condition: Non-inferiority Trial
- Intervention (Drug): Continuation of daily low-dose Aspirin
- Intervention (Drug): Discontinuation of daily low-dose Aspirin
- Lead sponsor: Odense University Hospital
- Lead sponsor class: OTHER
- Collaborator: University Hospital Bispebjerg and Frederiksberg
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Odense University Hospital (`cardio:org-odense-university-hospital`)
- Registry lists this organization as a collaborator: University Hospital Bispebjerg and Frederiksberg (`cardio:org-university-hospital-bispebjerg-and-frederiksberg`)

## Provenance

Content hash: 61dfbb40fa3a7162e6b430c0f6f5d5fe45b23e6285e540e7513a4028cf767bb6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
